Endurant Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,938	Closed	-$1.2M	–	73
2021 Q3	$1.2M	Buy	+22,938	New	+$1.2M	0.27%	45
2019 Q2	–	Sell	-61,155	Closed	-$2.01M	–	66
2019 Q1	$2.01M	Buy	61,155 +48,655	+389%	+$1.6M	0.8%	34
2018 Q4	$260K	Buy	+12,500	New	+$260K	0.14%	48